Dr. Whitley is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
University Of Minnesota Physicians
516 Delaware Street Se, Room 4-100
Minneapolis, MN 55455Phone+1 612-626-6777
Education & Training
- University of MinnesotaResidency, Pediatrics, 1980 - 1985
- University of Minnesota Medical SchoolClass of 1980
Certifications & Licensure
- MN State Medical License 1981 - 2025
- American Board of Medical Genetics and Genomics Clinical Biochemical Genetics
- American Board of Medical Genetics and Genomics Clinical Genetics
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory EMR, Epic Systems Corporation, 2012-2013
Clinical Trials
- A Natural History Study of the Gangliosidoses Start of enrollment: 2010 Dec 01
- Expanded Access Trial of Plant Expressed Recombinant Glucocerebrosidase (prGCD) in Patients With Gaucher Disease
- Safety and Efficacy of Gabapentin for Neuropathic Pain in Fabry Disease Start of enrollment: 2012 Apr 01
- Join now to see all
Publications & Presentations
PubMed
- 220 citationsEfficacy of sapropterin dihydrochloride (tetrahydrobiopterin, 6R-BH4) for reduction of phenylalanine concentration in patients with phenylketonuria: a phase III random...Harvey L. Levy, Andrzej Milanowski, Anupam Chakrapani, Maureen Cleary, Philip Lee
Lancet. 2007-08-11 - 13 citationsProteomic analysis of mucopolysaccharidosis I mouse brain with two-dimensional polyacrylamide gel electrophoresis.Li Ou, Michael J. Przybilla, Chester B. Whitley
Molecular Genetics and Metabolism. 2017-01-01 - 28 citationsGene therapy for neurologic manifestations of mucopolysaccharidoses.Daniel A. Wolf, Sharbani Banerjee, Perry B. Hackett, Chester B. Whitley, R. Scott McIvor
Expert Opinion on Drug Delivery. 2015-01-20
Press Mentions
- Lysogene Provides Updates and Topline Results from Phase 2/3 AAVance Gene Therapy Clinical StudyNovember 18th, 2022
- Sangamo (Part V): Assessing the Prospects of SB-913September 11th, 2018
- U.S. Scientists Try Gene Editing Inside a Person for the First Time, Aiming to Cure a DiseaseNovember 14th, 2017
Grant Support
- Lysosomal Disease Network-8th Annual World SymposiumEunice Kennedy Shriver National Institute Of Child Health &Human Development2012
- SB Transposons For Gene TherapyEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Research Animal Care And MedicineEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Neuro-Histology &BehaviorEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- In Vivo Lentiviral Gene Therapy For Hurler SyndromeEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- AdministrationEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- AAV Mediated Gene Therapy To The CNS For MPS IEunice Kennedy Shriver National Institute Of Child Health &Human Development2011
- Rdcrc Administrative UnitNational Institute Of Neurological Disorders And Stroke2009–2011
- Lysosomal Disease NetworkNational Institute Of Neurological Disorders And Stroke2009–2011
- Gene Therapy For Metabolic DisordersEunice Kennedy Shriver National Institute Of Child Health &Human Development1995–2011
- World Symposium 2010 (Lysosomal Disease Network'S 6th Annual Research Meeting)National Institute Of Neurological Disorders And Stroke2010
- World Symposium 2009 (Lysosomal Disease Network'S 5th Annual Research Meeting)National Institute Of Neurological Disorders And Stroke2009
- Pku-008: Phenoptin In PhenylketonuriaNational Center For Research Resources2007–2009
- Pku-007: A Phase 2, Multicenter, Open-Label Study To Evaluate The Safety And EffNational Center For Research Resources2007–2009
- Lysosomal Disease Network-4th Annual World SymposiumNational Institute Of Neurological Disorders And Stroke2008
- Lentiviral Gene Therapy For MPS Type IEunice Kennedy Shriver National Institute Of Child Health &Human Development2004–2008
- Lysosomal Disease Network-3rd Annual World SymposiumNational Institute Of Neurological Disorders And Stroke2007
- A Phase 3, Multicenter, Open-Label Extension Study Of Phenoptin In Subjects WithNational Center For Research Resources2006–2007
- Pku-003 Phase 3 Phenoptin In PKUNational Center For Research Resources2006
- A Phase 2, Multicenter, Open-Label Study To Evaluate The Response To And SafetyNational Center For Research Resources2006
- Agal-02503: Multi-Center, Open-Label Study Of The Safety And Efficacy Of FabrazyNational Center For Research Resources2005–2006
- Lysosomal Disease Network-2nd Annual World SymposiumNational Institute Of Neurological Disorders And Stroke2005
- World Lysosomal Research Network Annual SymposiumNational Institute Of Neurological Disorders And Stroke2004
- Lentiviral Ex Vivo Hematopoietic Stem Cell Gene Therapy For MPS IEunice Kennedy Shriver National Institute Of Child Health &Human Development2000–2001
- REAL Time Quantitative PCR Detection SystemNational Center For Research Resources1999
- Retroviral Mediated Transfer Of The Iduronate-2-Sulfatase Gene Into LymphocytesNational Center For Research Resources1997–1999
- Hematopoietic Stem Cell Gene Therapy For Hurler SyndromeEunice Kennedy Shriver National Institute Of Child Health &Human Development1996–1999
- Bone Marrow Transplantation For MucopolysaccharidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1988–1993
- 1st International Congress On MucopolysaccharidosisNational Institute Of Diabetes And Digestive And Kidney Diseases1988
External Links
- Lysosomal Disease Networkhttp://www.lysosomaldiseasenetwork.org/
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: